AKRO – Akero Therapeutics Inc

Name : Akero Therapeutics, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $0.00000000000000

EPSttm :

[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=AKRO #%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]

[iframe https://api.stockdio.com/visualization/financial/charts/v1/PricesChange?app-key=F086EEE750E14D8D8A456DB88B2D6D8C&symbol=AKRO &conditionalVolume=false&allowPeriodChange=false&tooltipsStyle=None&palette=Financial-Light&showBorderAndTitle=false 300 200 ]

Float Short %

5.75

Margin Of Safety %

Put/Call OI Ratio

2.8

EPS Next Q Diff

-0.02

EPS Last/This Y

EPS This/Next Y

-0.29

Price

54.65

Target Price

55.5

Analyst Recom

Performance Q

22.48

Relative Volume

Beta

-0.37

Ticker: AKRO

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-13	AKRO	54.2	0.84	0.90	33360
2025-11-14	AKRO	54.26	0.84	0.14	33320
2025-11-17	AKRO	54.34	0.84	3.75	33361
2025-11-18	AKRO	54.33	0.86	0.93	33742
2025-11-19	AKRO	54.34	0.87	0.15	33983
2025-11-20	AKRO	54.26	0.87	6.50	34031
2025-11-21	AKRO	54.28	0.87	11.25	34125
2025-11-24	AKRO	54.33	1.80	7.75	21460
2025-11-25	AKRO	54.35	1.88	2.72	22597
2025-11-26	AKRO	54.35	1.90	0.12	22989
2025-12-01	AKRO	54.44	1.93	10.69	23766
2025-12-02	AKRO	54.5	2.45	0.06	26944
2025-12-03	AKRO	54.69	2.56	5.17	27023
2025-12-04	AKRO	54.62	2.92	0.03	30835
2025-12-05	AKRO	54.54	2.76	4.42	31312
2025-12-08	AKRO	54.66	2.80	0.67	32412
2025-12-09	AKRO	54.65	2.80	0.15	32412
2025-12-10	AKRO	54.65	2.80	0.15	32412
2025-12-11	AKRO	54.65	2.80	0.15	32412
2025-12-12	AKRO	54.65	2.80	0.15	32412
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-13	AKRO	54.22	10.1	-	-3.74
2025-11-14	AKRO	54.25	10.1	-	-3.74
2025-11-17	AKRO	54.34	10.1	-	-3.74
2025-11-18	AKRO	54.33	1.2	-	-3.94
2025-11-19	AKRO	54.34	1.2	-	-3.94
2025-11-20	AKRO	54.24	1.2	-	-3.94
2025-11-21	AKRO	54.31	1.2	-	-3.94
2025-11-24	AKRO	54.33	1.2	-	-3.94
2025-11-25	AKRO	54.36	1.2	-	-3.94
2025-11-26	AKRO	54.34	0.4	-	-3.94
2025-12-01	AKRO	54.44	0.4	-	-3.94
2025-12-02	AKRO	54.49	0.4	-	-3.94
2025-12-03	AKRO	54.69	0.4	-	-3.94
2025-12-04	AKRO	54.62	0.4	-	-3.94
2025-12-05	AKRO	54.55	0.4	-	-3.94
2025-12-08	AKRO	54.65	0.4	-	-3.94
2025-12-09	AKRO	0.00	0.4	-	-3.94
2025-12-10	AKRO	54.65	0.4	-	-3.94
2025-12-11	AKRO	54.65	0.4	-	-3.94
2025-12-12	AKRO	54.65	0.4	-	-3.94
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-13	AKRO	-3.85	11.34	6.07
2025-11-14	AKRO	-3.56	11.34	6.07
2025-11-17	AKRO	-3.56	18.81	6.07
2025-11-18	AKRO	-3.59	18.81	6.04
2025-11-19	AKRO	-3.72	18.81	6.04
2025-11-20	AKRO	-3.62	18.81	6.04
2025-11-21	AKRO	-3.62	18.81	6.06
2025-11-24	AKRO	-3.49	-0.77	5.60
2025-11-25	AKRO	-3.54	-0.77	6.05
2025-11-26	AKRO	-3.54	-0.77	5.92
2025-12-01	AKRO	-3.57	-0.74	5.92
2025-12-02	AKRO	-3.56	-0.74	5.92
2025-12-03	AKRO	-3.56	-0.74	5.94
2025-12-04	AKRO	-3.50	-0.74	5.94
2025-12-05	AKRO	-3.46	-0.74	5.94
2025-12-08	AKRO	-3.46	-0.79	5.94
2025-12-09	AKRO	-3.46	-0.79	5.94
2025-12-10	AKRO	-3.09	-0.79	5.77
2025-12-11	AKRO	-3.09	-0.79	5.77
2025-12-12	AKRO	-3.09	-0.79	5.75
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

[stock_market_widget type="chart" template="candlestick" assets="AKRO " range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=AKRO 589 360 ]

Last Quarter Act. EPS

-0.99

Avg. EPS Est. Current Quarter

-0.99

Avg. EPS Est. Next Quarter

-1.01

Insider Transactions

-3.09

Institutional Transactions

-0.79

Beta

-0.37

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

6.4

Max Drawdown 5-Year %

Target Price

55.5

P/E

Forward P/E

PEG

P/S

P/B

4.57

P/Free Cash Flow

EPS

-3.75

Average EPS Est. Cur. Y

-3.94

EPS Next Y. (Est.)

-4.22

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

-57.5

Return on Equity vs Industry %

-42.5

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.2

EBIT Estimation

[iframe https://widget.finnhub.io/widgets/recommendation?symbol=AKRO 589 450 ]

[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=AKRO 589 450 ]

[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”AKRO ” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”AKRO ” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”AKRO ” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”AKRO ” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”AKRO ” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”AKRO ” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”AKRO ” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

Akero Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 74

Akero Therapeutics, Inc. engages in developing transformational treatments for patients with serious metabolic diseases in the United States. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21 that protects against cellular stress and regulates the metabolism of lipids, carbohydrates, and proteins throughout the body for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) patients. It has a license agreement with Amgen Inc. to develop, manufacture, use, distribute, and sell EFX as a treatment for MASH and other metabolic diseases. The company was formerly known as Pippin Therapeutics, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California. As of December 9, 2025, Akero Therapeutics, Inc. operates as a subsidiary of Novo Nordisk A/S.

stock quote shares AKRO – Akero Therapeutics Inc Stock Price stock today

news today AKRO – Akero Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch AKRO – Akero Therapeutics Inc yahoo finance google finance

stock history AKRO – Akero Therapeutics Inc invest stock market

stock prices AKRO premarket after hours

ticker AKRO fair value insiders trading

AKRO – Akero Therapeutics Inc

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: AKRO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y